Skip to main content

Table 7 Multivariate logistic regression analysis adusted odds ratio (95%CL) for antioxidant enzyme activities with COPD comorbidities: type 2 diabetes, pulmonary hypertension and cardiovascular

From: Altered antioxidant enzyme activity with severity and comorbidities of chronic obstructive pulmonary disease (COPD) in South Indian population

Variables COPD
co-morbidities
OR 95% CI p-values
Superoxide dismutase (U/mg protein) T2D 1.99 -1.11 – 2.49 0.453
PHT 1.61 -0.57 – 1.53 0.374
CVD 2.32 -0.35 – 2.04 0.169
Catalase (U/mg protein) T2D 1.98 -0.62 – 2.00 0.306
PHT 0.80 -1.14 – 0.70 0.642
CVD 1.77 -0.30 – 1.45 0.199
Glutathione s transferase (U/mg protein) T2D 0.90 -1.39 – 1.18 0.873
PHT 1.41 -0.57 – 1.26 0.462
CVD 2.51 0.00 – 1.84 <0.049
Glutathione peroxidase (U/mg protein) T2D 0.04 -6.60 – 0.53 <0.096
PHT 0.82 -1.12 – 0.72 0.677
CVD 0.63 -1.52 – 0.59 0.392
Glutathione reductase (U/mg protein) T2D 0.58 -1.76 – 0.70 0.400
PHT 0.52 -1.67 – 0.40 0.228
CVD 0.57 -1.60 – 0.49 0.299
Total antioxidant status (μM Fe2+/l) T2D 1.04 -1.07 – 1.16 0.934
PHT 1.26 -0.61 – 1.08 0.589
CVD 1.69 -0.45 – 1.50 0.291
  1. Significance of difference between erythrocyte antioxidant enzyme activities with COPD comorbidities: type 2 diabetes (T2D), pulmonary hypertension (PHT) and cardiovascular disease (CVD) p < 0.05; Border line significance: if p < 0.09; OR odds ratio, CI confidence interval